0001114220-18-000006.txt : 20180122
0001114220-18-000006.hdr.sgml : 20180122
20180122082251
ACCESSION NUMBER: 0001114220-18-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180118
FILED AS OF DATE: 20180122
DATE AS OF CHANGE: 20180122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carberry Christine A.
CENTRAL INDEX KEY: 0001694459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 18538848
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DRIVE, 12TH FLOOR
STREET 2: C/O KERYX BIOPHARMACEUTICALS, INC.
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wf-form4_151662735770222.xml
FORM 4
X0306
4
2018-01-18
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001694459
Carberry Christine A.
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Operating Officer
Common Stock
2018-01-18
4
S
0
9048
4.87
D
75952
D
Sale of a total of 9,048 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 28,334 shares of restricted stock on January 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 56,666 shares of restricted stock.
/s/ Brian Adams, Attorney-in-Fact
2018-01-22